Novo CEO pressed by Senate to chop price ranges of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the corporate would consider new talks with insurers in regards to the record prices of Wegovy and copyright when they pledge to maintain the medicines on their own formularies. Sanders https://daveshotchickencalories64107.frewwebs.com/31214414/the-smart-trick-of-healthcare-news-that-no-one-is-discussing